Ben Swann takes a look at the highly unusual timeline by which Moderna Therapeutics is developing its C0-vId 19 virus vaccine. Now, 4 scientists with the NIH claim they hold partial patent rights on that vaccine and stand to make up to $150,000 per year. Meanwhile, as Moderna’s stock price continues to soar, 5 top executives have sold off $89 million dollars’ worth of shares, even as the company continues to bypass standard vaccine protocols in the development of its C0-vId v@ccine.
Support Truth in Media by visiting our sponsors:
Pulse Cellular: Use code “TRUTH” for 10% off every plan for life.
Pure VPN: Military grade VPN protection.
Brave Browser: Open source and built by a team of privacy-focused, performance-oriented pioneers of the web.